BIONTECH SE

BNTX
Delayed Quote. Delayed  - 04/09 04:00:00 pm
122.14USD +6.68%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.

Number of employees : 1 941 people.
Sales per Business
2020
USD
(in Million)
%
Immunotherapy Technologies 549.84100%
Sales per region
20192020
USD
(in Million)
%USD
(in Million)
%
Germany 121.54100% 549.84100%
Managers
Name Title
Ugur Sahin Chief Executive Officer
Sierk Pötting Chief Operating & Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Christoph Huber Member-Supervisory Board
Michael Motschmann Member-Supervisory Board
Ulrich Wandschneider Member-Supervisory Board
Sylke Maas VP-Investor Relations & Business Strategy
Sean Marett Chief Business & Commercial Officer
Ryan Richardson Chief Strategy Officer
Shareholders
Name Equities %
PRIMECAP Management Co. 4,628,197 1.92%
Fidelity Management & Research Co. LLC 2,886,269 1.20%
T. Rowe Price Associates, Inc. (Investment Management) 1,574,821 0.65%
Artisan Partners LP 1,426,574 0.59%
Bill & Melinda Gates Foundation Trust (Investment Management) 1,038,674 0.43%
Invus Public Equities Advisors LLC 1,000,000 0.41%
Susquehanna Financial Group LLLP 591,720 0.24%
Redmile Group LLC 580,746 0.24%
Temasek Holdings Pte Ltd. (Investment Management) 537,634 0.22%
HealthCor Management LP 503,920 0.21%
Company contact information
BioNTech SE
An der Goldgrube 12
Mainz, Rheinland-Pfalz 55131

Phone : +49.6131.9084.0
Web : http://www.biontech.de
Sector Bio Therapeutic Drugs
1st jan.Capi. (M$)
BIONTECH SE49.83%29 499
GILEAD SCIENCES, INC.11.76%81 977
VERTEX PHARMACEUTICALS-9.73%55 220
REGENERON PHARMACEUTICALS-1.64%49 486
WUXI APPTEC CO., LTD.8.52%45 479
BEIGENE, LTD.19.30%28 269
GENMAB A/S-13.52%22 260
ARGENX SE-3.60%14 224
HUALAN BIOLOGICAL ENGINEERING INC.1.18%11 613
NEUROCRINE BIOSCIENCES, INC.-2.61%8 770
MIRATI THERAPEUTICS, INC.-22.52%8 616
ACCELERON PHARMA INC.-0.85%7 681
FATE THERAPEUTICS, INC.-14.23%7 323
EXELIXIS, INC.15.20%7 213
ULTRAGENYX PHARMACEUTICAL INC.-25.25%6 928
GW PHARMACEUTICALS PLC88.83%6 872
ASCENDIS PHARMA A/S-24.69%6 762
BIOCON LIMITED-9.69%6 664
ARROWHEAD PHARMACEUTICALS, INC.-19.00%6 451
DENALI THERAPEUTICS INC.-37.61%6 323
HALOZYME THERAPEUTICS, INC.0.14%6 171
Brand Portfolio
BIONTECH
BIONTECH
NEON THERAPEUTICS
NEON THERAPEUTICS
» More brands of BioNTech SE